MedPath

Clinical Efficacy of Supraclavicular Block for Arthroscopic Shoulder Surgery

Not Applicable
Completed
Conditions
Horner's Syndrome
Interventions
Other: Supraclavicular block
Other: Interscalene block
Registration Number
NCT01958801
Lead Sponsor
Daegu Catholic University Medical Center
Brief Summary

The aim of this study is to compare the efficacy of supraclavicular and interscalene brachial plexus blocks in the patients undergoing arthroscopic shoulder surgery.

Detailed Description

This study aims to compare supraclavicular brachial plexus block to interscalene brachial plexus block with regard to degree of sensory and motor blockades, side effects and complications of the blocks, and frequency of intraoperative analgesics or antihypertensives use.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
104
Inclusion Criteria
  • American Society of Anesthesiologists physical status I-II
  • Body mass index < 35 kg/m2
Exclusion Criteria
  • Neurologic deficits on the side to be blocked
  • Infection or inflammation at the puncture site for brachial plexus block
  • Psychiatric disorders
  • Patient refusal
  • Difficulty to communicate
  • Coagulation deficiencies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Supraclavicular blockSupraclavicular blockSupraclavicular block is performed under ultrasound guidance. Linear probe is placed on the ipsilateral supraclavicular fossa visualizing the brachial plexus located lateral to the subclavian artery. Using in-plane technique, nerve stimulation needle is advanced into the brachial plexus sheath, into which 25 ml of 1.5% mepivacaine is injected.
Interscalene blockInterscalene blockInterscalene block is performed under ultrasound guidance. Linear probe is placed on the ipsilateral interscalene groove visualizing the brachial plexus located between anterior and middle scalene muscles. Using in-plane technique, nerve stimulation needle is advanced into the brachial plexus sheath, into which 25 ml of 1.5% mepivacaine is injected.
Primary Outcome Measures
NameTimeMethod
Degree of sensory blockade20 minutes after the end of local anesthetics injection

Sensory blockade of the C5 to T1 dermatomes was assessed by rating the absence of cold sensation between 100 (intact sensation) and 0 (no sensation) with an alcohol swab.

Secondary Outcome Measures
NameTimeMethod
Side effects20 minutes after the end of local anethetics injection

Horner's syndrome (ptosis, miosis, anhidrosis) Subjective dyspnea Hoarseness

Frequency of intraoperative analgesics or antihypertensives useAt the end of the surgery

Frequency of intraoperative use of opioids (fentanyl) or antihypertensives (hydralazine)

Degree of motor blockade20 minutes after the end of local anethetics injection

Motor blockade was evaluated by elbow and wrist extension (radial nerve), finger abduction (ulnar nerve), wrist flexion (median nerve), and elbow flexion (musculocutaneous nerve). The muscle force was rated on a scale of 0 to 6 as follows (6: normal muscle force; 5: slightly reduced muscle force; 4: greatly reduced muscle force; 3: slightly impaired mobility; 2: greatly impaired mobility; 1: near complete paralysis; 0: complete paralysis).

Trial Locations

Locations (1)

Daegu Catholic University Medical Center

🇰🇷

Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath